United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · IEX Real-Time Price · USD
262.40
+4.27 (1.65%)
At close: May 3, 2024, 4:00 PM
264.49
+2.09 (0.80%)
After-hours: May 3, 2024, 6:33 PM EDT
United Therapeutics Employees
United Therapeutics had 1,168 employees on December 31, 2023. The number of employees increased by 183 or 18.58% compared to the previous year.
Employees
1,168
Change (1Y)
183
Growth (1Y)
18.58%
Revenue / Employee
$2,138,955
Profits / Employee
$899,401
Market Cap
11.64B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,168 | 183 | 18.58% |
Dec 31, 2022 | 985 | 20 | 2.07% |
Dec 31, 2021 | 965 | 15 | 1.58% |
Dec 31, 2020 | 950 | 30 | 3.26% |
Dec 31, 2019 | 920 | 60 | 6.98% |
Dec 31, 2018 | 860 | 60 | 7.50% |
Dec 31, 2017 | 800 | 50 | 6.67% |
Dec 31, 2016 | 750 | 0 | - |
Dec 31, 2015 | 750 | 10 | 1.35% |
Dec 31, 2014 | 740 | 34 | 4.82% |
Dec 31, 2013 | 706 | 83 | 13.32% |
Dec 31, 2012 | 623 | 80 | 14.73% |
Dec 31, 2011 | 543 | 23 | 4.42% |
Dec 31, 2010 | 520 | 110 | 26.83% |
Dec 31, 2009 | 410 | 50 | 13.89% |
Dec 31, 2008 | 360 | 40 | 12.50% |
Dec 31, 2007 | 320 | 35 | 12.28% |
Dec 31, 2006 | 285 | 75 | 35.71% |
Dec 31, 2005 | 210 | 40 | 23.53% |
Dec 31, 2004 | 170 | 10 | 6.25% |
Dec 31, 2003 | 160 | 10 | 6.67% |
Dec 31, 2002 | 150 | 22 | 17.19% |
Dec 31, 2001 | 128 | 18 | 16.36% |
Dec 31, 2000 | 110 | 47 | 74.60% |
Dec 31, 1999 | 63 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Tenet Healthcare | 106,500 |
Charles River Laboratories International | 21,800 |
Smith & Nephew | 19,081 |
Catalent | 17,800 |
Exact Sciences | 6,600 |
Medpace Holdings | 5,900 |
Natera | 3,293 |
Bio-Techne | 3,050 |
UTHR News
- 3 days ago - United Therapeutics Corporation Reports First Quarter 2024 Financial Results - Business Wire
- 8 days ago - CORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney Transplant - Business Wire
- 10 days ago - United Therapeutics Announces World's First Successful Xenothymokidney Transplant - Business Wire
- 10 days ago - United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024 - Business Wire
- 18 days ago - United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference - Business Wire
- 5 weeks ago - United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation - Business Wire
- 5 weeks ago - United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program - Business Wire
- 2 months ago - United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024 - Business Wire